VALEANT PHARMACEUTICALS INTERNATIONAL CORPORATION

Valeant Pharmaceuticals International Corporation specializes in the manufacturing of pharmaceutical preparations, with demonstrated experience supplying specialized drugs, hematological agents, and related therapeutics to federal healthcare systems. Their technical expertise lies in the formulation, production, and quality-controlled distribution of complex pharmaceutical products, adhering to cGMP standards and regulatory requirements for federal procurement. The company’s focus on hematologic and specialty drug products suggests deep capability in handling high-complexity, low-volume formulations requiring stringent stability and sterility controls, positioning them as a niche supplier for clinically critical medications. The Department of Veterans Affairs is the only known federal customer, indicating a targeted relationship centered on fulfilling the VA’s pharmaceutical supply needs under the Federal Supply Schedule. This suggests alignment with VA’s mandate to provide consistent, reliable access to specialty medications for veteran populations, particularly in areas such as oncology, immunology, and blood disorder therapeutics. The primary industry focus is on NAICS 325412 — Pharmaceutical Preparation Manufacturing — which encompasses the production of finished dosage forms including tablets, injectables, and other standardized pharmaceuticals. The company operates within the specialty pharmaceutical segment, serving government health systems that require clinically validated, FDA-approved products with complex supply chain requirements. Valeant Pharmaceuticals International Corporation is structured as a private pharmaceutical manufacturer with no publicly disclosed government certifications. While specific geographic presence is not indicated, their contract with the VA implies a national footprint in federal pharmaceutical distribution. Their market positioning is that of a specialized supplier to government healthcare entities, emphasizing product integrity, regulatory compliance, and reliable delivery of mission-critical medications.